npcr

Natural Products Chemistry & Research

ISSN - 2329-6836

Opinion Article - (2022) Volume 10, Issue 1

Withania somnifera- Characteristics, Uses and Side effects

Robert W Buchanan*
 
*Correspondence: Robert W Buchanan, Faculty of Medicine and Pharmaceutical Sciences, St. Johns University of Medicines, United States, Email:

Author info »

Abstract

Withania somnifera is an annual evergreen shrub belonging to family Solanaceae grows in India, the Middle East, and parts of Africa. Though it is used for medicinal purpose in Ayurveda, there is insufficient scientific evidence that it is safe in use. The herb is neuroprotective and antiinflammatory in nature. It boosts energy and reduces stress and anxiety.

Keywords

Solanaceae • Anxiety • Ayurveda

Characteristics of Withania Somnifera

It reaches only 1ft-2 ft but in some cases 6 ft. It is a perennial plant but can be grown as an annual plant too. Plant and fruits resemble ground cherry and Chinese lantern. Young roots are straight, unbranched and conical in shape and of different lengths. Root thickness varies according to age while the outer surface is yellow and wrinkled longitudinally. Tastes bitter and mucilaginous.

Chemical Constituents of Withania somnifera

The plants main constituent is alkaloid withanine and it contains pseudowithanine, somniferine, tropine and pseudotropine and etc. The leaves contain steroid lactone, known as withanolides.

Uses of Withania somnifera

Withania somnifera may possess anti-inflammatory properties

Withania somnifera extracts in the treatment of cancer

• Testosterone seen increasing in infertile men

• The decrease in cortisol has been found in humans

• Improvements in power output have been noted in trained people’s subject to a sprint performance

Withania somnifera appears to reduce the symptoms of stress, fatigue, temporary cognitive impairment, etc.

• There is a decrease in total cholesterol when Withania somnifera is ingested

• A small decrease in blood glucose and blood pressure has been noted

Withania somnifera is able to increase seminal motility

• Weight decrease has been seen when Withania somnifera is taken

• Every part is used including roots, bark, leaves, fruit and seed are used to treat various diseases such as nervous disorders, intestinal infections and leprosy

• Induction of polyploidy Hori culture

Side effects of Withania somnifera

• Gastrointestinal symptoms like nausea, upset stomach, and diarrhoea

• It may help you sleep better at night; drowsiness can be an unwelcome side effect for some users

Who should avoid consumption of Withania somnifera

• It is unsafe in pregnancy because it can induce abortions, can cause miscarriage, premature birth, or even uterine contractions

• It alters thyroid function and increase thyroid hormones, which could be dangerous for people with hyperthyroidism

• People with stomach ulcers should avoid

• People with high blood pressure need to avoid using Withania somnifera

Withania somnifera in India holds a position of importance similar to ginseng in China. It acts mainly on the reproductive and nervous systems, and is used to improve vitality and aid recovery after chronic disease. It is also used to treat nervous exhaustion and insomnia. It can be applied as a poultice to boils, swellings and other painful parts. Withania somnifera is considered as an adaptogen and so is used in number of diseases. It is considered possibly safe when taken daily for up to 3 months.

Acknowledgement

The author is very thankful to all the associated personnel in any reference that contributed to/for the purpose of this research.

Conflict of Interest

The author has declared that no competing interests exist.

Author Info

Robert W Buchanan*
 
Faculty of Medicine and Pharmaceutical Sciences, St. Johns University of Medicines, United States
 

Citation: Buchanan RW. Withania somnifera- Characteristics, Uses and Side effects. Nat Prod Chem Res. 2022, 10 (1), 001-002.

Received: 28-Dec-2021, Manuscript No. NPCR-21-13327; Editor assigned: 08-Jan-2022, Pre QC No. NPCR-21-13327 (PQ); Reviewed: 15-Jan-2022, QC No. NPCR-21-13327; Revised: 25-Jan-2022, Manuscript No. NPCR-21-13327 (R); Published: 29-Jan-2022, DOI: 10.37532/npcr.10.1.1-2

Copyright: © 2022 Buchanan RW. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.